Engineering next-generation, brain-penetrant cancer therapeutics.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $25M
Founded date: 2017
Investors 10
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.02.2021 | Series A | $25M | Ridgeback ... |
Mentions in press and media 9
| Date | Title | Description |
| 05.02.2021 | Reverie Labs Raises $25M in Series A Funding | Reverie Labs, a Cambridge, Mass.-based pharmaceutical company pioneering the application of machine learning to developing next-generation small molecule kinase inhibitors, closed its $25M Series A financing. In conjunction with the financi... |
| 03.02.2021 | Reverie Labs raises $25 million for its AI drug discovery platform | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Reverie Labs, a startup using AI to develop new m... |
| 03.02.2021 | Daily funding roundup - February 3rd, 2021 | Rightfoot raised $5M; Flosonics Medical picks up $14M; Evinced landed $17M; DealerPolicy secured $3 Polytomic: Polytomic is a Bay Area-based startup that says it synchs internal data to business systems. Polytomic just raised $2.4 million i... |
| 03.02.2021 | Reverie Labs Raises $25M Series A Round | Reverie Labs, a pharmaceutical company pioneering the application of machine learning to developing next-generation small molecule kinase inhibitors, today announced the closure of its $25M Series A financing, and the addition of Wayne Holm... |
| 03.02.2021 | Reverie Labs : Raises $25M Series A Round to Broaden Impact of its Computational Kinase Drug Discovery Platform | CAMBRIDGE, Mass., Feb. 3, 2021 /PRNewswire/ -- Reverie Labs, a pharmaceutical company pioneering the application of machine learning to developing next-generation small molecule kinase inhibitors, today announced the closure of its $25M Ser... |
| 03.02.2021 | Reverie Labs raises $25 million for its AI drug discovery platform | Reverie Labs, a startup using AI to develop new medicines, today announced the closure of its $25 million series A round. The company says the capital will be used to advance its internal and partnered drug discovery program, further develo... |
| 19.03.2018 | Here are 64 startups that launched today at Y Combinator’s W18 Demo Day 1 | Biotech, robotics, and fintech startups took the spotlight today at Y Combinator’s 26th Demo Day. This batch features 141 total companies from 23 countries, with presentations spread over two days. The house was packed at Mountain View’s Co... |
| 19.03.2018 | 14 Companies From YC Winter 2018 | Meet 14 companies that announced they’re part of the YC Winter 2018 batch. You can see more companies from the Winter 2018 batch here, here, here, here, here, and here. LUS Brands tackles the $50B+ global curly hair market. LUS bootstrappe... |
| 16.03.2018 | Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks | Developing new medicines can take years of research and cost millions of dollars before they are even ready for clinical trials. Several biotech startups are using machine learning to revolutionize the process and get drugs into pharmacies ... |